Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thomas Seth Kupper, M.D.

Co-Author

This page shows the publications co-authored by Thomas Kupper and Rachael Clark.
Connection Strength

7.429
  1. Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci Transl Med. 2012 Jan 18; 4(117):117ra7.
    View in: PubMed
    Score: 0.509
  2. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma. Blood. 2011 Feb 10; 117(6):1966-76.
    View in: PubMed
    Score: 0.472
  3. Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J Exp Med. 2008 Sep 29; 205(10):2221-34.
    View in: PubMed
    Score: 0.404
  4. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood. 2007 Jan 01; 109(1):194-202.
    View in: PubMed
    Score: 0.352
  5. Misbehaving macrophages in the pathogenesis of psoriasis. J Clin Invest. 2006 Aug; 116(8):2084-7.
    View in: PubMed
    Score: 0.349
  6. A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol. 2006 May; 126(5):1059-70.
    View in: PubMed
    Score: 0.343
  7. The vast majority of CLA+ T cells are resident in normal skin. J Immunol. 2006 Apr 01; 176(7):4431-9.
    View in: PubMed
    Score: 0.341
  8. Human skin cells support thymus-independent T cell development. J Clin Invest. 2005 Nov; 115(11):3239-49.
    View in: PubMed
    Score: 0.330
  9. Old meets new: the interaction between innate and adaptive immunity. J Invest Dermatol. 2005 Oct; 125(4):629-37.
    View in: PubMed
    Score: 0.329
  10. Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease. J Clin Invest. 2020 09 01; 130(9):4624-4636.
    View in: PubMed
    Score: 0.232
  11. Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence. Nat Cancer. 2020 Feb; 1(2):197-209.
    View in: PubMed
    Score: 0.222
  12. Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides. Clin Cancer Res. 2020 01 15; 26(2):408-418.
    View in: PubMed
    Score: 0.218
  13. High-throughput sequencing of the T cell receptor ß gene identifies aggressive early-stage mycosis fungoides. Sci Transl Med. 2018 05 09; 10(440).
    View in: PubMed
    Score: 0.197
  14. A primary role for human central memory cells in tissue immunosurveillance. Blood Adv. 2018 02 13; 2(3):292-298.
    View in: PubMed
    Score: 0.194
  15. Staged development of long-lived T-cell receptor aß TH17 resident memory T-cell population to Candida albicans after skin infection. J Allergy Clin Immunol. 2018 08; 142(2):647-662.
    View in: PubMed
    Score: 0.191
  16. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing aß T cell clones. J Clin Invest. 2017 Nov 01; 127(11):4031-4041.
    View in: PubMed
    Score: 0.189
  17. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature. 2017 03 09; 543(7644):252-256.
    View in: PubMed
    Score: 0.181
  18. TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci Transl Med. 2015 Oct 07; 7(308):308ra158.
    View in: PubMed
    Score: 0.165
  19. Common clonal origin of central and resident memory T cells following skin immunization. Nat Med. 2015 Jun; 21(6):647-53.
    View in: PubMed
    Score: 0.160
  20. Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci Transl Med. 2015 Mar 18; 7(279):279ra39.
    View in: PubMed
    Score: 0.159
  21. Alemtuzumab therapy for leukemic cutaneous T-cell lymphoma: diffuse erythema as a positive predictor of complete remission. JAMA Dermatol. 2014 Jul; 150(7):776-9.
    View in: PubMed
    Score: 0.151
  22. Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci Transl Med. 2014 Jan 15; 6(219):219ra8.
    View in: PubMed
    Score: 0.146
  23. TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res. 2013 Jul 15; 19(14):3755-63.
    View in: PubMed
    Score: 0.141
  24. CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-?, IL-13, IL-17, and IL-22. J Invest Dermatol. 2013 Apr; 133(4):973-9.
    View in: PubMed
    Score: 0.135
  25. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med. 2012 Aug; 18(8):1248-53.
    View in: PubMed
    Score: 0.132
  26. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity. 2012 May 25; 36(5):873-84.
    View in: PubMed
    Score: 0.130
  27. Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature. 2012 Feb 29; 483(7388):227-31.
    View in: PubMed
    Score: 0.128
  28. Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity. PLoS One. 2011 Jan 26; 6(1):e16245.
    View in: PubMed
    Score: 0.119
  29. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood. 2010 Aug 05; 116(5):767-71.
    View in: PubMed
    Score: 0.113
  30. Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin. J Invest Dermatol. 2009 Nov; 129(11):2676-85.
    View in: PubMed
    Score: 0.106
  31. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol. 2006 Oct 01; 177(7):4488-94.
    View in: PubMed
    Score: 0.088
  32. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma. Clin Cancer Res. 2006 Jan 15; 12(2):376-82.
    View in: PubMed
    Score: 0.084
  33. Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma. Blood. 2006 Mar 15; 107(6):2440-5.
    View in: PubMed
    Score: 0.083
  34. Skin-resident natural killer T cells participate in cutaneous allergic inflammation in atopic dermatitis. J Allergy Clin Immunol. 2021 05; 147(5):1764-1777.
    View in: PubMed
    Score: 0.060
  35. Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma. . 2017 10; 16(10):2304-2314.
    View in: PubMed
    Score: 0.047
  36. Histopathologic spectrum of hypersensitivity reactions associated with anti-CD52 therapy (alemtuzumab). J Cutan Pathol. 2016 Nov; 43(11):989-993.
    View in: PubMed
    Score: 0.044
  37. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 07 11; 30(1):183.
    View in: PubMed
    Score: 0.043
  38. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 04 11; 29(4):574-586.
    View in: PubMed
    Score: 0.043
  39. Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood. 2015 Jul 16; 126(3):354-62.
    View in: PubMed
    Score: 0.040
  40. Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma. Blood. 2012 Apr 12; 119(15):3534-8.
    View in: PubMed
    Score: 0.032
  41. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell Melanoma Res. 2010 Jun; 23(3):375-84.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.